New drug aims to treat dangerous blood clotting disorder with fewer hospital procedures

NCT ID NCT05714969

Ongoing Disease control Sponsor: Takeda Source: ClinicalTrials.gov ↗

Summary

This study is testing an investigational drug called TAK-755 for adults experiencing a sudden, severe attack of immune-mediated thrombotic thrombocytopenic purpura (iTTP), a rare and life-threatening blood clotting disorder. The main goal is to see if TAK-755, given along with standard immunosuppressive therapy, can help patients recover without needing the usual intensive plasma exchange treatments in the hospital. Participants will receive the drug during their hospital stay and for about 6 weeks afterward, with the total study lasting around 3 months.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

AKH - Medizinische Universitat Wien

Vienna, 1090, Austria
Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino

Torino, 10126, Italy
Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States
Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States
Duke University Medical Center

Durham, North Carolina, 27710, United States
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico

Milan, 20122, Italy
General Hospital of Thessaloniki "G. Papanikolaou"

Thessaloniki, 57010, Greece
Hospital General Universitario Gregorio Maranon

Madrid, 28007, Spain
Hospital Universitari i Politecnic La Fe

Valencia, 46026, Spain
Hospital Universitario Virgen del Rocio

Seville, Sevilla, 41010, Spain
Hospital de Cruces

Barakaldo, Vizcaya, 48903, Spain
Leo Jenkins Cancer Center/ECU School of Medicine

Greenville, North Carolina, 27858, United States
Massachusetts General Hospital

Boston, Massachusetts, 02114, United States
Ohio State University

Columbus, Ohio, 43210, United States
Royal Liverpool University Hospital

Liverpool, Merseyside, L7 8XP, United Kingdom
Rutgers University

New Brunswick, New Jersey, 08901, United States
University College London Hospital

London, Greater London, NW1 2PG, United Kingdom
University of Florida - Shands

Gainesville, Florida, 32610, United States
University of Minnesota Clinical Research Unit

Minneapolis, Minnesota, 55455, United States
University of Utah Health Sciences Center

Salt Lake City, Utah, 84132, United States
Versiti Wisconsin, Inc.

Milwaukee, Wisconsin, 53226, United States
Weill Cornell

New York, New York, 10021, United States

Conditions

Explore the condition pages connected to this study.

THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)